Mersana Therapeutics Inc. (MRSN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
4:31 pm
Purchase
2025-06-3013GMersana Therapeutics, Inc.
MRSN
Schonfeld Strategic Advisors LLC5,673,852
4.550%
5,369,289increase
(+1762.95%)
Filing
History
2025-07-17
7:54 pm
Sale
2025-06-3013GMersana Therapeutics, Inc.
MRSN
BlackRock Inc.
BLK
150,475
3.000%
-182,480decrease
(-54.81%)
Filing
History
2025-05-15
5:48 pm
Sale
2025-03-3113GMersana Therapeutics, Inc.
MRSN
Venrock Healthcare Capital Partners III, L.P.142,973
2.900%
-267,339decrease
(-65.16%)
Filing
History
2025-05-15
4:31 pm
Purchase
2025-03-3113GMersana Therapeutics, Inc.
MRSN
Schonfeld Strategic Advisors LLC304,563
6.110%
304,563increase
(New Position)
Filing
History
2025-05-15
2:16 pm
Sale
2025-03-3113GMersana Therapeutics, Inc.
MRSN
EcoR1 Capital, LLC0
0.000%
-463,138decrease
(Position Closed)
Filing
History
2025-04-30
11:23 am
Purchase
2025-03-3113GMersana Therapeutics, Inc.
MRSN
The Vanguard Group335,111
6.720%
85,607increase
(+34.31%)
Filing
History
2025-04-17
09:35 am
Sale
2025-03-3113GMersana Therapeutics, Inc.
MRSN
BlackRock Inc.
BLK
332,955
6.700%
-35,253decrease
(-9.57%)
Filing
History
2025-02-14
6:15 pm
Sale
2024-12-3113GMersana Therapeutics, Inc.
MRSN
Venrock Healthcare Capital Partners III, L.P.410,312
8.300%
-42,808decrease
(-9.45%)
Filing
History
2025-02-05
1:23 pm
Purchase
2024-12-3113GMersana Therapeutics, Inc.
MRSN
BlackRock Inc.
BLK
368,207
8.000%
54,436increase
(+17.35%)
Filing
History
2024-12-26
4:29 pm
Unchanged
2024-12-2013GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a. r.l.482,690
10.400%
0
(Unchanged)
Filing
History
2024-12-23
7:50 pm
Sale
2024-12-1913GMersana Therapeutics, Inc.
MRSN
EcoR1 Capital, LLC463,138
9.990%
-311,450decrease
(-40.21%)
Filing
History
2024-11-15
4:45 pm
Purchase
2024-11-1313DMersana Therapeutics, Inc.
MRSN
Bain Capital Life Sciences Fund II, L.P.198,720
4.000%
37,051increase
(+22.92%)
Filing
History
2024-11-14
5:45 pm
Purchase
2024-09-3013GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a. r.l.482,690
9.800%
232,736increase
(+93.11%)
Filing
History
2024-11-14
06:01 am
Sale
2024-09-3013GMersana Therapeutics, Inc.
MRSN
Balyasny Asset Management L.P.21,433
0.440%
-366,493decrease
(-94.48%)
Filing
History
2024-10-15
06:55 am
Sale
2024-10-1113GMersana Therapeutics, Inc.
MRSN
SILVERARC CAPITAL MANAGEMENT LLC70,163
1.430%
-186,642decrease
(-72.68%)
Filing
History
2024-05-17
08:26 am
Purchase
2024-05-1413GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a. r.l.249,954
5.100%
249,954increase
(New Position)
Filing
History
2024-02-14
8:56 pm
Purchase
2023-12-3113GMersana Therapeutics, Inc.
MRSN
Venrock Healthcare Capital Partners III, L.P.453,120
9.400%
66,000increase
(+17.05%)
Filing
History
2024-02-14
8:43 pm
Purchase
2023-12-3113GMersana Therapeutics, Inc.
MRSN
SILVERARC CAPITAL MANAGEMENT LLC256,805
5.300%
256,805increase
(New Position)
Filing
History
2024-02-14
6:55 pm
Sale
2023-12-3113GMersana Therapeutics, Inc.
MRSN
ORBIMED ADVISORS LLC0
0.000%
-283,313decrease
(Position Closed)
Filing
History
2024-02-14
09:20 am
Sale
2023-12-3113GMersana Therapeutics, Inc.
MRSN
Avoro Capital Advisors LLC0
0.000%
-302,000decrease
(Position Closed)
Filing
History
Goto 0, 1, 2, Next